3124 Results
Sort By:
Published on January 12, 2023
The American Cancer Society (ACS) released today their annual report on cancer facts and trends, Cancer Statistics, 2023, showing overall cancer mortality has declined by 33% in the last 30 years, which translates to roughly 3.8 million deaths that were averted. The report also estimates that in the coming year,…
Published on August 8, 2022
Men’s greater susceptibility to cancer may be due to underlying biological sex differences rather than behavioral factors, such as smoking, alcohol use, and diet, according to results from a recent study published in Cancer. Men have a higher risk of cancer than women at most shared anatomic sites. Such male…
Published on July 24, 2024
A new study published in the Journal of the National Cancer Institute, has found that reducing disparities between Black and White people in colonoscopy follow-up completion rates and the quality of colonoscopy screenings would dramatically reduce colon cancer deaths. According to the study’s findings, efforts aimed at eliminating these disparities…
Published on July 24, 2024
A new study from the Mayo Clinic finds that current screening protocols fail to catch a significant number of individuals with genetic mutations linked to hereditary breast and ovarian cancer syndrome (HBOC) and Lynch syndrome, which increase the risk of developing certain cancers. Their findings, published in JCO Precision Oncology,…
Published on July 24, 2024
Huntsman Cancer Institute researchers have shown that less than a third of patients with metastatic prostate cancer or advanced urothelial carcinoma undergo next-generation sequencing (NGS), even though these tumors may have mutations that could be used to guide treatment. The NGS rates have increased over time, but were lower among…
Published on May 29, 2024
A team of researchers led by Kim Eunjung, PhD, at the Natural Products Informatics Research Center of the Korea Institute of Science and Technology (KIST) has developed a mathematical model that provides a theoretical foundation to predict tumor evolution that could provide a method of providing more effective adaptive cancer…
Published on May 1, 2024
Cancer screening rates are significantly lower at Federally Qualified Health Centers (FQHCs) compared to overall national rates, according to a study published in JAMA Internal Medicine. The study found screening use in FQHCs was 45.4 percent for breast cancer, 51 percent for cervical cancer and 40.2 percent for colorectal cancer,…
Published on April 17, 2024
A retrospective study led by researchers at Washington University School of Medicine in St. Louis and Whiterabbit.ai showed that an artificial intelligence (AI)-based protocol theoretically reduced the number of false positive results from routine mammograms. The study is published in Radiology: Artificial Intelligence. Acknowledging that many AI-based studies in breast…
Published on April 10, 2024
More than half of cancer drugs granted accelerated approval between 2013 and 2017 did not demonstrate a significant improvement in overall survival (OS) or quality of life (QoL) within five years of approval, shows an analysis of U.S. Food and Drug Administration (FDA) data. The study by postdoctoral research fellow…
Published on April 2, 2024
Researchers at the Kyushu University in Japan say they have developed a machine-learning model that can accurately evaluate the density of surviving cells in the malignant bone cancer osteosarcoma from pathological images which can provide a more accurate patient prognosis compared with conventional methods. The research is reported in njp…
Published on January 29, 2024
Research led by the University Illinois Chicago shows a common genetic test, used by clinicians to help decide on treatment for women with estrogen receptor (ER) positive breast cancer, is less accurate in Black women. The Oncotype DX 21-gene test creates a recurrence score that is designed to show which…
Published on January 3, 2024
SimBioSys, which specializes in spatial biophysics and artificial intelligence (AI), has recently entered into a strategic collaboration with Mayo Clinic to advance digital precision medicine solutions for breast cancer patients. The collaboration will develop cloud-based clinical software tools that will guide the decision-making process for early-stage breast cancer patients, covering…
Published on December 27, 2023
New research shows that two types of per-and polyfluroalkyl substances (PFAS), or ‘forever chemicals,’ spurred cancer cells to migrate to new positions in lab and mouse studies, an indication that the chemicals could contribute to cancer metastasis. The work was spurred by the fact that firefighters experience this type of…
Published on December 4, 2023
Two separate studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center show why some prostate cancers can become resistant to hormone therapies—the most common treatment for men with advanced stage disease. The new research efforts provide new information about how cells use the energy to influence the way…
Published on November 30, 2023
In a clinical validation study, Veracyte’s Percepta Nasal Swab Test determined lung cancer risk with high accuracy, among people who currently smoke or have previously smoked and have lung nodules. The findings suggest the novel, non-invasive, genomic test can help physicians better decide next steps for these patients. Low-risk patients…